Effect of Calcitonin on Pain Relief in Patients with Fractures

Effect of Calcitonin on Healing Duration and Pain Relief in Patients with Maxillofacial Fracture

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190409043211N1

Enrollment

Registered

2019-04-28

Start date

2019-04-08

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: mandibular fracture. Condition 2: maxillofacial fracture. Fracture of mandible Fracture of malar, maxillary and zygoma bones

Interventions

Intervention 1: Intervention group: Single dose of intranasal calcitonin (200 unit). Intervention 2: Control group: intranasal NaCl spray.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with maxillofacial fracture which happened within less than a week

Exclusion criteria

Exclusion criteria: Systemic conditions impairing wound healing Patient mental illness Allergy to calcitonin Calcium metabolism disorder

Design outcomes

Primary

Measure	Time frame
Pain due to maxillofacial fracture. Timepoint: At 1? 2? 3? 4? 5? 6? and 7 day after drug. Method of measurement: Visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzin Ahmadpour

Tabriz University of Medical Sciences

phoenixinfire@ymail.com+98 41 3335 5965

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026